Prescription Pattern of Antihypertensive Agents in T2DM Patients Visiting Tertiary Care Centre in North India
Open Access
- 18 December 2012
- journal article
- research article
- Published by Hindawi Limited in International Journal of Hypertension
- Vol. 2012, 1-9
Abstract
Background. Hypertension management is of a paramount importance in diabetic patients for cardiovascular risk reduction.Aim. To evaluate prescribing pattern of antihypertensive in T2DM (type 2 diabetes) patients and compare with existing recent guidelines.Methods. A cross-sectional study involving evaluation of all T2DM patients referred to endocrinology unit at tertiary care centre for hypertension, comorbid complications, and recording prescription. Utilization of 5 different antihypertensive drug classes was compared for all patients receiving 1, 2, 3, 4, or more drugs. Logistical regression was used to assess likelihood of prescription of drugs and/or therapy for specific conditions mentioned in the guidelines.Results. Out of 1358, T2DM enrolled patients 1186 (87%) had hypertension (males 52%, females 48%). The median duration (IQ) of hypertension diabetics was 4 (1–10) years. A total of 25% patients had controlled BP and 75% with uncontrolled blood pressure (13% isolated systolic hypertension, 6% isolated diastolic hypertension, and 55% both elevated). Overall, ACE inhibitors (ACEIs) were prescribed the highest (59%) followed by angiotensin receptor blockers (ARBs) (52%), calcium channel blockers (CCBs) (29%), diuretics (27%), and beta-blockers (14%). Overall, 55% of T2DM patients were on polytherapy, 41% on monotherapy, and 4% had no antihypertensive treatment. Polytherapy was more predominant with age, duration of diabetes, duration of hypertension, and comorbid complications.Conclusion. Although prescribing pattern of antihypertensive showed adherence to existing evidence-based guidelines, higher proportion of uncontrolled hypertensive patients was found.Keywords
This publication has 44 references indexed in Scilit:
- The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysisCanadian Medical Association Journal, 2011
- Comparison of the Framingham Heart Study Hypertension Model With Blood Pressure Alone in the Prediction of Risk of HypertensionHypertension, 2010
- Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for HypertensionDiabetes Care, 2008
- Standards of Medical Care in Diabetes—2008Diabetes Care, 2008
- Global burden of hypertension: analysis of worldwide dataThe Lancet, 2005
- Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertensionJACC, 2004
- British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summaryBMJ, 2004
- Incidence of hypertension and non-insulin dependent diabetes mellitus and associated risk factors in a rapidly developing Caribbean community: the St James survey, Trinidad.Journal of Epidemiology and Community Health, 1996
- Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research GroupJAMA, 1991
- Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogenJournal of Clinical Pathology, 1969